LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 72 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $425,000 | -10.1% | 13,698 | -6.7% | 0.01% | -12.5% |
| Q4 2017 | $473,000 | -10.1% | 14,684 | -2.9% | 0.01% | -11.1% |
| Q3 2017 | $526,000 | -46.5% | 15,119 | -54.3% | 0.01% | -43.8% |
| Q2 2017 | $984,000 | -9.4% | 33,059 | -9.2% | 0.02% | -11.1% |
| Q1 2017 | $1,086,000 | +54.0% | 36,398 | -9.5% | 0.02% | +50.0% |
| Q4 2016 | $705,000 | -32.1% | 40,237 | -7.9% | 0.01% | -29.4% |
| Q3 2016 | $1,039,000 | +39.7% | 43,685 | -6.0% | 0.02% | +41.7% |
| Q2 2016 | $744,000 | -17.2% | 46,476 | +8.1% | 0.01% | -20.0% |
| Q1 2016 | $899,000 | +42.2% | 43,011 | +83.8% | 0.02% | +50.0% |
| Q4 2015 | $632,000 | +66.3% | 23,402 | +70.9% | 0.01% | +66.7% |
| Q3 2015 | $380,000 | – | 13,691 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |